Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Search content at Johns Hopkins University
Home
Profiles
Research units
Research output
Autoimmune phenotypes in schizophrenia reveal novel treatment targets
Emily G. Severance
, Faith B. Dickerson
,
Robert H. Yolken
School of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
17
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Autoimmune phenotypes in schizophrenia reveal novel treatment targets'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Schizophrenia
100%
Novel Therapeutic Targets
100%
Autoimmune
100%
Disease States
14%
Inflammation
14%
Psychiatric Research
14%
Immune Activation
14%
Infectious Agents
14%
Immune System
14%
Neurotransmitter Receptors
14%
Autoantibodies
14%
Dysregulated
14%
Drug Discovery
14%
Drug Class
14%
Dopamine
14%
Autoimmunity
14%
Novel Agents
14%
Pharmaceutics
14%
Pharmacotherapy
14%
Dopaminergic Pathway
14%
Atypical Antipsychotics
14%
Microbiome
14%
Complement Pathway
14%
New Frontiers
14%
Hypofunction
14%
Gut-brain Axis
14%
Synaptic Pruning
14%
Typical Antipsychotics
14%
Objective Biomarker
14%
Dysbioses
14%
Treatment Lines
14%
Antipsychotic Drugs
14%
CNS Pathology
14%
Autoimmune Dysfunction
14%
Dysbiotic
14%
Study Circles
14%
Pharmacology, Toxicology and Pharmaceutical Science
Schizophrenia
100%
Dopamine
28%
Inflammation
14%
Pharmacotherapy
14%
Biological Marker
14%
Pathophysiology
14%
Neurotransmitter Receptor
14%
Autoantibodies
14%
Drug Discovery
14%
Infectious Agent
14%
Typical Antipsychotic
14%
Atypical Antipsychotics
14%
Microbiome
14%
Diseases
14%
Side Effect
14%
Antipsychotic Drug
14%
Neuroscience
Schizophrenia
100%
Dopamine
28%
Neurotransmitter Receptor
14%
DNA Template
14%
Typical Antipsychotic
14%
Atypical Antipsychotic
14%
Autoantibodies
14%
Drug Therapy
14%
Antipsychotic
14%
Side Effect
14%
Biological Marker
14%